Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.

The global cardiac marker testing market was valued at approximately USD 4.02 billion in 2022 and is expected to grow at a CAGR of 9.4% from 2023 to 2030. Cardiac marker testing involves the analysis ...

Jacob Temple is warning people about the health consequences of e-cigarettes, saying 12 years of vaping led to him having a ...

HASSAN: With the district reporting 21 deaths due to heart attacks in the last one month, the Hassan administration held an ...

Delayed diagnosis is a serious issue in modern medicine. Explore conditions that are frequently diagnosed too late or ...

In recent years, heart attacks among young adults have been on the rise—a shift that has become more pronounced since the ...

Heart attacks are no longer the leading cause of heart disease-related death, but deaths from heart disease have still been ...

A scientific statement has been published by the AHA regarding the relationship between alcohol use and cardiovascular disease.

Older adults, obese individuals, and those with a history of heart failure or myocardial infarction are also more susceptible. Lifestyle factors like smoking, physical inactivity, and a poor diet can ...

The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...

Dr Amal Mattu breaks down the key updates — and lingering pitfalls — in the 2025 ACS guidelines that every acute care ...